PlattR.MunozA.StellaJ.VandevanterS.KosterJKJr.Antibiotic prophylaxis in cardiovascular surgery—efficacy with coronary artery bypass. Ann Intern Med1984; 101: 770–4.
2.
DudleyMNNightingaleCHQuintilianiR.TiltonRC. In vitro activity of cefonicid, ceforanide, and cefazolin against Staphylococcus aureus and Staphylococcus epidermidis and the effect of human serum. J Infect Dis1983; 148: 178.
3.
AyersLWJonesRNBarryAL., Cefotetan, a new cephamycin: Comparison of in vitro antimicrobial activity with other cephems, β-lactamase stability, and preliminary recommendations for disk diffusion testing. Antimicrob Agents Chemother1982; 22: 859–77.
4.
MuytjensHLVan Der Ros-Van DeRepe J.Comparative activities of 13 β-lactam antibiotics. Antimicrob Agents Chemother1982; 21: 925–34.
5.
CountsGWTurckM.Antibacterial activity of a new parenteral cephalosporin-HR 756: Comparison with cefamandole and ceforanide. Antimicrob Agents Chemother1979; 16: 64–8.
6.
JonesRNThornsberryC.BarryALFuchsPCGavanTLGerlachEH. BL-S786, a new parenteral cephalosporin II—in vitro antimicrobial activity comparison with six related cephalosporins. J Antibiot1977; 30: 583–92.
7.
LaverdiereM.WelterD.SabathLD. Use of a heavy inoculum in the in vitro evaluation of the anti-staphylococcal activity of 19 cephalosporins. Antimicrob Agents Chemother1978; 13: 669–75.
8.
LeitnerF.MisiekM.PursianoTA., Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity. Antimicrob Agents Chemother1976; 10: 426–35.
